BioMedical Strategy, led by Dr. Orna Oz, is a unique and highly qualified consulting group providing pre-clinical, clinical and regulatory strategic planning. We are committed to delivering healthcare product companies with the utmost efficient and cost-effective approach for product entry to the world markets, including the U.S., Europe, Israel and elsewhere.
"Highly dedicated, professional team that do not only provide advise but perform end-to-end writing and support the company throughout the entire process, from the strategy to the execution phase of development."
Nir Israeli, CEO, Sanoculis
“They will tell you what you need to hear instead of what you want to hear, leading to a fast and more cost-effective process.”
Omer Zelka, Founder & CEO, ElastiMed
“Orna & her group take the time to become part of your company’ DNA. Their in-depth knowledge about our product and its competitive landscape were crucial for the process to succeed. Their clinical evaluation report was excellent, and we received the CE approval."
Livnat Ben-Zur, General Manager & VP Business Development, Regentis Biomaterials
"Orna and her team are our first-in-line for any FDA submission activity, as well as professional services for clinical regulatory documentation."
Yehudit Kraizer, Director Regulatory Affairs, Lumenis Israel
"Orna & her team are the most suitable consulting group for a startup because of their ability to simultaneously lead the process with extraordinary expertise while having the flexibility to adapt to the ever-changing needs of a startup."
Avner Halperin, CEO, Earlysense
"Complete Transparency. Honest & Expert Feedback."
Sholmzion Shen, Co-Founder & CEO,
Seevix Material Sciences
Contact us and find how our services can benefit your company.
@ our TLV offices
Beit Shavit, 4th floor
4 Raoul Wallenberg St.
Tel Aviv-Yafo 6971904,
@ our Haifa offices
Eshel building, 3rd floor
2 Pal Yam St.